重复肾上腺静脉采血在醛固酮增多症中的可重复性及不一致结果解读
该单中心回顾性研究纳入23例确诊原发性醛固酮增多症患者共46组肾上腺静脉采血(AVS),评估重复AVS的生化结果与诊断偏侧化的可重复性。结果显示促肾上腺皮质激素(cosyntropin)输注后肾上腺醛固酮/皮质醇(A/C)比值相关性更好,所有病例最终偏侧化诊断一致,初次失败AVS重复操作成功率75%。
要点
- 重复AVS在初次失败后仍可行且成功率较高。
- cosyntropin输注后A/C比值重复性优于输注前。
- 重复AVS的最终偏侧化诊断与初次一致。
核心结论
- 重复AVS是可行且通常成功的,尤其当初次操作失败时。
- 重复AVS的个体肾上腺A/C比值和偏侧化指数呈中等相关性。
- 所有病例的最终偏侧化诊断在重复AVS中完全相同,表明AVS是可靠且可重复的定位试验。
研究设计与样本
- 单中心、单操作者AVS操作的回顾性病历回顾。
- 纳入23例确诊原发性醛固酮增多症(PA)患者,因技术成功疑虑或诊断结果不一致而重复AVS,共46组AVS。
- 重复AVS中位间隔3个月。
- 采用一致方案:cosyntropin输注前和输注后同时进行AVS。
- 成功插管标准为选择性指数≥2;偏侧化诊断标准为偏侧化指数≥3。
主要发现
- 在成功插管的肾上腺静脉中,cosyntropin输注前肾上腺静脉和下腔静脉的A/C比值呈中等相关(Spearman r=0.49-0.59,P<.05)。
- cosyntropin输注后相关性更好(Spearman r=0.67-0.76,P<.05)。
- 在技术成功的AVS中,重复偏侧化指数呈中等相关(Spearman r=0.53,P<.05)。
- 15例因与CT成像显示偏侧化不一致而重复AVS的患者,第二次AVS的最终诊断相同。
- 初次失败AVS在重复尝试中成功率为75%。
关键数值与推荐
- 选择性指数≥2定义为成功插管。
- 偏侧化指数≥3定义为诊断偏侧化。
- cosyntropin输注前A/C比值重复性Spearman r=0.49-0.59(P<.05)。
- cosyntropin输注后A/C比值重复性Spearman r=0.67-0.76(P<.05)。
- 重复偏侧化指数相关性Spearman r=0.53(P<.05)。
临床怎么用
- 对于初次AVS失败或结果不一致的原发性醛固酮增多症患者,可考虑重复AVS。
- 采用cosyntropin输注方案可能提高AVS生化结果的可重复性。
- 重复AVS的最终偏侧化诊断与初次一致,支持其作为可靠定位试验用于临床决策。
局限性
- 单中心、单操作者的回顾性研究,样本量较小(23例患者,46组AVS)。
- 仅纳入因技术成功疑虑或诊断不一致而重复AVS的患者,存在选择偏倚。
- 中位重复间隔3个月,长期可重复性未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The reproducibility of adrenal vein sampling (AVS) is unknown. OBJECTIVE: This work aimed to determine reproducibility of biochemical results and diagnostic lateralization in patients undergoing repeat AVS. METHODS: A retrospective chart review was conducted of single-center, single-operator AVS procedures at a tertiary care center. Included were patients with confirmed primary aldosteronism (PA) undergoing repeat AVS because of concerns about technical success or discordant diagnostic results. Simultaneous AVS was performed by an experienced operator using a consistent protocol of precosyntropin and postcosyntropin infusion. Among successfully catheterized adrenal veins (selectivity index ≥ 2), the correlation of the adrenalaldosterone/cortisol (A/C) ratio was measured between the first and second AVS. The secondary outcome measure was diagnostic agreement on repeat AVS lateralization (lateralization index ≥ 3). RESULTS: There were 46 sets of AVS from 23 patients at a median of 3 months apart. There was moderate correlation in A/C ratios in the adrenal veins and inferior vena cava (Spearman r = 0.49-0.59, P < .05) pre cosyntropin. Post cosyntropin, the correlation was better (Spearman r = 0.67-0.76, P < .05). In technically successful AVS, there was moderate correlation between the repeated lateralization indices (Spearman r = 0.53, P < .05). In 15 patients in whom repeat AVS was performed because of apparent lateralization discordance with computed tomography imaging, the final diagnosis was the same in the second AVS procedure. Initial failed AVS was successful 75% of the time on repeat attempt. CONCLUSION: Repeat AVS was feasible and usually successful when an initial attempt failed. There was modest correlation between individual repeat adrenal A/C ratios and lateralization indices when AVS was performed twice. The final lateralization diagnosis was identical in all cases. This demonstrates that AVS is a reliable and reproducible localizing test in PA.
引用
- Kline GA, Leung AA, Sam D, et al. Repeat Adrenal Vein Sampling in Aldosteronism: Reproducibility and Interpretation of Persistently Discordant Results. J Clin Endocrinol Metab. 2021. PMID: 33320942. doi:10.1210/clinem/dgaa930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。